2019台灣生技月 Bio Taiwan 生物科技大展

2019 台灣生技月 南港展覽館

PROGRAM

BIO Asia–Taiwan Conference

​​

Session Speakers list so far confirmed. Check back regularly for updates

 

July 24 (Wednesday)

Venue: 3F, Bldg. A, CTBC Financial Park

 

Plenary Session – Global Development in Biotechnology

Ballroom A

08:00-09:00

Registration

09:00-09:05

Welcoming Remarks
Johnsee Lee, Chairman, Taiwan Bio Industry Organization

09:05-09:20

Opening Remarks
James C. Greenwood, President and CEO, Biotechnology Innovation Organization (BIO)

09:20-09:55

Towards Accelerated Medical Innovation
Jeff Karp, Professor of Medicine, Harvard Medical School & MIT Brigham and Women's Hospital

09:55-10:25

David Fuller MBBS, Senior Vice President Clinical Development, (JAPAC), Syneos Health

10:25-10:40

Break 

10:40-11:10

Joseph Damond, Executive VP, International Affairs, Biotechnology Innovation Organization (BIO)

11:10-11:40

Milasen: The First Truly Personalized Medicine
Timothy Yu, Boston Children’s Hospital / Harvard Medical School (Inviting)

11:40-12:15

Panel Discussion
Moderator: Johnsee Lee, Chairman, Taiwan Bio Industry Organization
Panelists: all speakers above

 

Luncheon – Bio Clusters as a Growth Engine

Ballroom A

12:25-12:30

Opening Remarks

12:30-13:40

Dar-Bin Shieh, Deputy Minister, Ministry of Science and Technology
Toshio Fujimoto, General Manager, Shonan Health Innovation Park
Alexander Bedenkov, Vice President for International Medical Affairs, AstraZeneca

13:30-13:50

Conclusion

 

Session 1 – An Exciting Year of Investment and Innovation

Ballroom A

14:00-14:05

Welcome & Opening Remarks

14:05-14:25

Biomedical Venture Capital Trends
Yi Shi, Managing Partner, Lilly Asia Ventures

14:25-14:45

Biomedical Capital Market
Sam Thong, Managing Director, Morgan Stanley Hong Kong

14:45-15:05

Global Technology Trend - the State of Asia Biotech
Kerry Blanchard, Chief Science Officer, Innovent Biologics

15:05-15:25

Break

15:25-15:45

Industry Trend of Genomic Sequencing and Precision Medicine
Victor Shi, Chairman, BayHelix Group

15:45-16:05

M&A and Licensing from Big Pharma’s Perspectives
Gregg Talbert, Global Head of Digital and Personalised Healthcare Partnering, Roche (inviting)

16:05-16:30

Panel Discussion
Moderator: Yi Shi, Managing Partner, Lilly Asia Ventures
Panelists:
Robert Liu, Executive Vice President & Managing Director, CDIB Capital Group
and all speakers above

 

Session 2 – AI for Biotech & Healthcare

Ballroom B

14:10-14:15

Opening Remarks
Session Chair: Chien-Huang Lin, President, Taipei Medical University

14:15-14:40

AI on Healthcare: Taiwan’s Competitiveness and Opportunities
Ethan Tu, Founder, Taiwan AI Labs

14:40-15:05

Shun Doi, President & CEO, NEC CYTLIMIC

15:05-15:30

Representative from AstraZeneca (Inviting)

15:30-15:55

AI for Virtual Trials (TBC)
Josh Rose, Vice President, Global Head of Strategy, IQVIA

15:55-16:10

Break

16:10-16:35

Simon See, Director, Nvidia AI Technology Center

16:35-17:00

Wei-Tech ANG, Associate Professor, School of Mechanical & Aerospace Engineering, Nanyang Technological University

17:00-17:25

Biomedical Signals Analysis and Healthcare
Chung-Kang Peng, Professor, Center for Dynamical Biomarkers, Beth Israel Deaconess Medical Center, Harvard Medical School, Harvard University

17:25-18:10

Panel Discussion
Moderator: Yu-Chuan (Jack) Li, Dean, College of Medical Science and Technology, Taipei Medical University
Panelists: all speakers above

18:30-21:00

BIO Asia-Taiwan 2019 Banquet 

  Ballroom A


​  

July 25 (Thursday)

Venue: 3F, Bldg. A, CTBC Financial Park

 

Session 3 – Advances in Precision Medicine

Ballroom A

08:30-09:00

Registration

09:00-09:05

Welcoming Remarks

09:05-09:20

Precision Oncology - Trends and Future
Simranjit Singh, CEO Asia, Middle East & Africa, Guardant Healthcare

09:20-09:55

Rajiv Rana, Head of Medical Affairs APAC, Merck

09:55:-10:25

Representative from Amgen (Inviting) 

10:25-10:40

Break 

10:40-11:10

(Inviting)

11:10-11:40

Clinical Applications and Regulatory Frameworks in Precision Medicine -- From Taiwan to Asia
Jarret C.J. Su, Head of Healthcare, KPMG 

11:40-12:15

Panel Discussion
Moderator: Johnsee Lee, Chairman, Taiwan Bio Industry Organization
Panelists: all speakers above

 ​

Session 4 – Cross Border Investments

Ballroom A

14:00-14:05

Welcoming Remarks
Session Chair: PwC Taiwan

14:05-14:30

Opportunities in Crossborder Investments
Katherine Andersen, Head of U.S. Life Science & Healthcare Banking Silicon Valley Bank (inviting)

14:30-14:55

IPO talk of Hong Kong
Scott Liu, Co-founder, President and CEO, Henlius Biotech

14:55-15:20

IPO talk of US
Samantha Du, Chairman and CEO, Zai Lab

15:20-15:40

Break 

15:40-16:05

M&A talk from seller perspectives
Kuo Liang Yu, Chairman and CTO, Crown Bioscience

16:05-16:30

M&A talk from PE perspectives
Jim Tsao, Chairman and Head of China, Permira Private Equity Fund

16:30-16:55

M&A talk from buyer perspectives
Jung Chin Lin, Chairman of Center Laboratories Group

16:55-17:40

Panel Discussion
Moderator:
Panelists: all speakers above

 

Luncheon – Sharing Biotech Successes

Ballroom A

12:15-12:20

Welcome Remarks
Johnsee Lee, Chairman, Taiwan Bio Industry Organization 

12:20-13:50

Sharing the Experience of Biotech Success
Session Chair:Johnsee Lee
 
2019 Taiwan Bio Industry Organization Award
   Outstanding Company of the Year
   Emerging Company of the Year
   Innovation of the Year
 
Discussion and Q&A

 

Session 5 – Regional Collaboration & Opportunity

  Ballroom B

08:30-09:00

Registration

09:00-09:05

Welcome & Opening Remarks

09:05-09:30

Opening Speech:
Joshua Berlin, Executive Director, BioCentury Inc.

09:30-09:55

Atsushi Hasuoka, APAC DAEWG

09:55-10:10

Break

10:10-10:35

Nares Damrongchai, CEO, TCELS

10:35-11:00

Eric Shao, Greater China Vice President, Head of Management Consulting, IQVIA

11:00-11:25

Collaboration and Investment Opportunities in China’s Healthcare Sector
Yu Rong, Chairman, Health 100; Chairman, TianYi Group

11:40-12:15

Panel Discussion
Moderator: Joshua Berlin, Executive Director, BioCentury Inc.
Panelists:
P.M.Murali,Chairman,  Jananom Private Limited.
and all speakers above

 

Session 6 – Protein Drugs and Combination Products

  Ballroom B

14:00-14:10

Welcoming Remarks

14:10-14:40

Judy Chou, SVP & Global Head of Biotech, Bayer

14:40-15:10

Alice Lin-Tsing Yu, Distinguished Chair Professor, Chang Gung University

15:10-15:40

Current Thoughts on Therapeutic Antibody Discovery & Development
Larry Lo, Sr. Director, R&D, Corvidia Therapeutics
 

15:40-15:55

Break 

15:55-16:25

Markus Bauss, Managing Director, SHL group

16:25-16:55

Proprietary Antibody Technologies
Wei-kuang Chi, Vice President, DCB

16:55-17:50

Panel Discussion
Moderator:
Panelists: all speakers above

 

July 26 (Friday)

Venue: 3F, Bldg. A, CTBC Financial Park

 

Session 7 – Cell & Gene Therapy

  Ballroom A

08:30-09:00

Registration

09:00-09:10

Welcome & Opening Remarks
Chung-hsiun Wu, CEO, Development Center for Biotechnology
Chien-Tsun Kuan, EVP/ COO & CTO, GenomeFrontier Therapeutics

09:10-09:35

Advancing Biotherapies—from Biologics to Cell Therapy
Philip G. Vanek, General Manager, Cell and Gene Therapy Strategy, GE Healthcare

09:35-10:00

TRuC™-T Cells: Redefining T Cell Therapy for Cancer
Robert Hofmeister, Chief Scientific Officer, TCR2 Therapeutics

10:00-10:25

FDA Perspective for CAR-T Cell Therapy
Yao Yi, CEO, BioCeltech

10:25-10:40

Break 

10:40-11:05

Japan’s Regenerative Medicine Environment Update
Masayuki Nomura, Member, Steering Committee , Forum for Innovative Regenerative Medicine 

1105:11:30

CRO Experience for Cell Therapy
Kazem Kazempour, President & CEO, Amarex Clinical Research, LLC.

11:30-11:55

Translational Research and Therapeutic Applications of Cell-based regenerative therapies
Jonas CT, Wang, Ph.D. Chairman/CEO, StemCyte International Ltd.

11:55-12:00

Conclusion

 

Session 8 – Investment for ICT x Bio

  Ballroom A

14:00-14:10

Welcome & Opening Remarks
Chii-Wann Lin, Vice President and General Director, Industrial Technology Research Institute

14:10-14:50

Strategic Focus in Developing Early Stage Digital Health Technologies - Similarities of Israel and Taiwan Relative Advantages
Talor Sax, CEO, eHealth Ventures

14:50-15:30

Capturing & Integrating ICT and Biomedical Innovations-From Industry Perspective (TBC)
Iduru Kokubu, Head of Healthcare Solutions UnitⅡ, Fujitsu

15:30-15:50

Break 

15:50-16:20

Healthcare & Bio ICT Businesses in Japan – How INFOCOM Transforms Us into Healthcare and Bio ICT Services Providers in Japan –
Yoichiro Hamazaki, Deputy Senior General Manager, Healthcare Business Division, INFOCOM Corporation

16:20-16:50

Best Applications for Smart Health Technologies - From Clinical Perspective (TBC)
Jou-Wei Lin, Vice Superintendent, National Taiwan University Hospital Yun-Lin Branch

16:50-17:10

Investment Strategy for eHealth (TBC)
Rick Wen, Partner & Health Care Sector Leader, Risk Management, Deloitte & Touche

17:10-17:50

Panel Discussion: Connecting Innovation, Investors and Industry from Biotech and ICT
Moderator: Chii-Wann Lin, Vice President and General Director, Industrial Technology Research Institute
Panelists: all speakers above

 

Luncheon – Challenges in Fighting Cancer

Ballroom A

12:15-12:20

Welcome Remarks

12:20-13:50

(Inviting)

 

Session 9 – Smart Hospital & Homecare

  Ballroom B

08:30-09:00

Registration

09:00-09:05

Welcome & Opening Remarks
Chien-Huang Lin, President, Taipei Medical University

09:05-09:20

Taiwan’s Vision on Healthcare Blockchain (TBC)
Yu-Jen Hsu, Legislator, Legislative Yuan / Commissioner of Asia, Global Blockchain Policy Council (Inviting)

09:20-09:35

Taiwan's "My Health Bank System"- An Application of Healthcare Database
Po-Chang Lee, Director General, National Health Insurance Administration, Ministry of Health and Welfare

09:35-09:50

Opportunities of Applying Cloud and IoMT Technology in BioHealth (TBC)
Tzi-Cker Chiueh, Vice President and General Director, Information and Communications Research Laboratories, Industrial Technology Research Institute  (Inviting)

09:50-10:05

Smart Healthcare Ecosystem
Ray-Jade Chen, Superintendent, Taipei Medical University Hospital

10:05-10:55

Panel Discussion
Moderator: Yu-Jen Hsu, Legislator, Legislative Yuan / Commissioner of Asia, Global Blockchain Policy Council (Inviting)
Panelists: all speakers above

10:55-11:10

Break 

11:10-11:15

Moderator: Ray-Jade Chen, Superintendent, Taipei Medical University Hospital

11:15:11:30

Representative from Roche Taiwan (Inviting)

11:30-11:45

Hansen QC Huang, AWS AI & Blockchain Services (Inviting)

11:45-12:00

AI & Blockchain Applications in TMUH
Representative from Taipei Medical University Hospital (Inviting)​

 

Session 10 – Gene Editing and Microbiome

  Ballroom B

14:00-14:05

Welcome & Opening Remarks
Session Chair: Fu-Tong, Liu, Vice President, Academia Sinica

14:05-14:30

Timothy Lu, Associate Professor, MIT

14:30-14:55

Michael McManus, Professor, Dept. of Microbiology and Immunology, UC San Francisco

14:55-15:20

Mouse Germline and Somatic Mutants Generated by CRISPR/Cas9 for Cancer Studies
You-Tzung Chen, Associate Professor, Graduate Institute of Medical Genomics and Proteomics, National Taiwan University College of Medicine

15:20-15:40

Break 

15:40-16:05

Chun-Ying Wu, Director Division of Translational Research, Taipei Veterans General Hospital

16:05-16:30

Heidi H. Kong, Investigator, Dermatology Branch/NIAMS, NIH

16:30-16:55

(Inviting)